Campaign to end pediatric HIV/AIDS launched in Africa

At the launch of the Campaign to End Pediatric HIV/AIDS (CEPA) on Thursday, advocate Graca Machel urged African leaders to redirect state spending to prevent and treat HIV infections among women and children, Agence France-Presse reports. An estimated "1.8 million of the world's two million [HIV-positive] children" live in Sub-saharan Africa, where "[m]other-to-child prevention and treatment coverage currently averages 30 to 40 percent against a target of 80 percent," the news service writes (10/22).

"No matter how small our budgets, we must do something. We will not get there (HIV reduction) with African leaders who don't get moved by people dying,"' Machel said, Reuters reports. CEPA will work with African governments to help ensure pregnant women living with HIV have access to antiretrovirals (ARVs) to help prevent the transmission of the virus to newborns (Govender, 10/22).

The program also aims to improve HIV-positive childrens' access to care and ARVs, Inter Press Service reports. "CEPA is a three-year campaign that will initially focus on six countries: Uganda, Kenya, Tanzania, Mozambique, Zambia and Nigeria. Of these six countries, Kenya has the highest number of HIV-positive children, 155,000," the news service writes. The article includes details about how Nigeria's decision to offer free ARVs increased the number of HIV-positive pregnant women on the drugs (Kalideen, 10/22).

According to a CEPA press release, the campaign seeks to overcome implementation and policy "bottlenecks," which "include inadequate health care worker training, and insufficient transportation systems for health care commodities; policy bottlenecks include lack of long‐term predictable financing, and the lack of clear national policies and targets for scaling up access to pediatric HIV/AIDS services" (10/22).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Unveiling the key role of RNA modification in HIV-1 survival and replication